Table 3.
Variable | N (%) | Univariable analysis | Multivariable analysis | |||
---|---|---|---|---|---|---|
Hazard Ratio (95% CI) | P | Hazard Ratio (95% CI) | P | |||
Immunotherapy | Neoadjuvant immunotherapy | 373 (1.09) | 0.88 (0.78–0.98) | 0.026 | 0.93 (0.82–1.05) | 0.220 |
No immunotherapy | 33,921 (98.91) | Ref | Ref | |||
CTx plus immunotherapy | Neoadjuvant CTx plus imm | 95 (0.53) | 0.835 (0.653–1.067) | 0.150 | 0.930 (0.725–1.195) | 0.572 |
Adjuvant CTx only | 17,868 (99.47) | Ref | ||||
CTxRT plus immunotherapy | Neoadjuvant CTxRTx plus imm | 258 (1.64) | 0.897 (0.781–1.030) | 0.122 | 0.942 (0.814–1.091) | 0.425 |
Adjuvant CTxRTx only | 15,466 (98.36) | Ref |
CTx: chemotherapy, CTxRTx: chemoradiation therapy, imm: immunotherapy